BioForce Nanosciences Holdings, Inc.
BFNH
$1.75
$0.04252.49%
Weiss Ratings | BFNH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Very Weak | |||
Risk Grade | E+ | |||
Reward Grade | E | |||
Rating Factors | BFNH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Very Weak | |||
Total Return Index | Fair | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | BFNH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.97 | |||
Price History | BFNH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.00% | |||
30-Day Total Return | 6.92% | |||
60-Day Total Return | -8.60% | |||
90-Day Total Return | -16.67% | |||
Year to Date Total Return | -15.42% | |||
1-Year Total Return | 66.67% | |||
2-Year Total Return | 18.06% | |||
3-Year Total Return | 277.78% | |||
5-Year Total Return | -70.43% | |||
52-Week High % Change | -37.91% | |||
52-Week Low % Change | 79.73% | |||
Price | BFNH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $2.75 | |||
52-Week Low Price | $0.95 | |||
52-Week Low Price (Date) | Apr 20, 2023 | |||
52-Week High Price (Date) | Aug 17, 2023 | |||
Valuation | BFNH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 53.57M | |||
Enterprise Value | 53.79M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.02 | |||
Earnings Per Share Growth | -2.20% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | -- | |||
Price/Book (Q) | -29.47 | |||
Enterprise Value/Revenue (TTM) | -- | |||
Price | $1.70 | |||
Enterprise Value/EBITDA (TTM) | -- | |||
Enterprise Value/EBIT | -106.38 | |||
Market Cap Category | Micro Cap | |||
Dividends and Shares | BFNH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 29.27M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | BFNH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 757 306 6090 | |||
Address | 2020 General Booth Boulevard Virginia Beach, VA 23454 | |||
Website | www.bioforceeclipse.com | |||
Country | United States | |||
Year Founded | 1999 | |||
Profitability | BFNH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -- | |||
Profit Margin | -- | |||
Management Effectiveness | BFNH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -45,375.00% | |||
Return on Equity | -- | |||
Income Statement | BFNH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | -- | |||
Total Revenue (TTM) | -- | |||
Revenue Per Share | -- | |||
Gross Profit (TTM) | -- | |||
EBITDA (TTM) | -- | |||
EBIT (TTM) | -471.90K | |||
Net Income (TTM) | -471.90K | |||
Net Income Avl. to Common (TTM) | -471.90K | |||
Total Revenue Growth (Q YOY) | -- | |||
Earnings Growth (Q YOY) | 0.26% | |||
EPS Diluted (TTM) | -0.02 | |||
EPS Diluted Growth (Q YOY) | 0.00% | |||
Balance Sheet | BFNH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 600.00 | |||
Cash Per Share (Q) | $0.00 | |||
Total Current Assets (Q) | 600.00 | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | -1.82M | |||
Current Ratio (Q) | 0.000 | |||
Book Value Per Share (Q) | -$0.06 | |||
Total Assets (Q) | 600.00 | |||
Total Current Liabilities (Q) | 1.82M | |||
Total Debt (Q) | 220.70K | |||
Total Liabilities (Q) | 1.82M | |||
Total Common Equity (Q) | -1.82M | |||
Cash Flow | BFNH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -- | |||
Cash from Financing (TTM) | 46.50K | |||
Net Change in Cash (TTM) | 0.00 | |||
Levered Free Cash Flow (TTM) | 130.30K | |||
Cash from Operations (TTM) | -46.70K | |||